SG
SGRY.US Surgery Partners Inc
- Market cap
- USD 3.50B
- P/E
- -
- P/B
- 2.11x
- ROE
- -5.8%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is SGRY.US undervalued?
Graham numberThe Graham number of Surgery Partners Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Surgery Partners Inc fundamental analysis
No fundamental analysis for Surgery Partners Inc yet.
Surgery Partners Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Surgery Partners Inc
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagno…
Full company profileSurgery Partners Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Surgery Partners Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.15B | 1.34B | 1.77B | 1.83B | 1.86B | 2.23B | 2.54B | 2.74B | 3.11B | 3.31B | 3.30B |
| Gross Profit | 324M | 327M | 410M | 424M | 380M | 491M | 575M | 648M | 746M | 765M | 663M |
| Operating Income | 196M | 158M | 77.8M | 236M | 183M | 302M | 345M | 328M | 349M | 390M | 360M |
| EBITDA | 245M | 252M | 145M | 310M | 278M | 401M | 460M | 446M | 501M | 566M | 496M |
| Net Income | 9.45M | -53.0M | -206M | -74.8M | -116M | -70.9M | -54.6M | -11.9M | -168M | -77.9M | -96.0M |
| EPS | 0.20 | -1.08 | -4.28 | -1.55 | -2.38 | -0.98 | -0.59 | -0.09 | -1.33 | -0.61 | -0.74 |
| Balance Sheet | |||||||||||
| Total Assets | 2.30B | 4.62B | 4.68B | 5.02B | 5.41B | 6.12B | 6.68B | 6.88B | 7.89B | 8.12B | 7.05B |
| Total Liabilities | 2.30B | 4.62B | 4.68B | 3.32B | 3.79B | 3.82B | 3.40B | 3.51B | 4.25B | 4.59B | 4.15B |
| Shareholders' Equity | 9.68M | 655M | 405M | 692M | 550M | 1.09B | 2.00B | 1.99B | 1.79B | 1.71B | 1.66B |
| Cash & Short-term Investments | 69.7M | 175M | 184M | 92.7M | 318M | 390M | 283M | 196M | 270M | 240M | 355M |
| Total Debt | 1.50B | 2.31B | 2.48B | 2.90B | 3.20B | 3.29B | 2.93B | 3.06B | 3.70B | 4.02B | 3.31B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 125M | 121M | 145M | 130M | 247M | 87.1M | 159M | 294M | 300M | 274M | 233M |
| Capital Expenditure | 39.1M | 29.6M | 39.8M | 73.6M | 42.9M | 57.6M | 80.6M | 88.8M | 90.4M | 78.7M | 83.1M |
| Free Cash Flow | 86.1M | 91.3M | 105M | 55.9M | 204M | 29.5M | 78.2M | 205M | 210M | 196M | 150M |
| Ratios | |||||||||||
| ROE | 97.7% | -8.1% | -50.8% | -10.8% | -21.1% | -6.5% | -2.7% | -0.6% | -9.4% | -4.5% | -5.8% |
| ROA | 0.4% | -1.1% | -4.4% | -1.5% | -2.1% | -1.2% | -0.8% | -0.2% | -2.1% | -1.0% | -1.4% |
| Net Profit Margin | 0.8% | -4.0% | -11.6% | -4.1% | -6.2% | -3.2% | -2.2% | -0.4% | -5.4% | -2.4% | -2.9% |
| Debt to Equity | 154.65x | 3.53x | 6.12x | 4.19x | 5.81x | 3.03x | 1.47x | 1.54x | 2.07x | 2.35x | 1.99x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Surgery Partners Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | USD 147M | 1.60 | - |
| 2021 | USD 5.10M | 0.07 | - |
| 2020 | USD 110M | 2.25 | - |
| 2019 | USD 121M | 2.51 | - |
| 2018 | USD 7.80M | 0.16 | - |
| 2017 | USD 1.32M | 0.03 | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Surgery Partners Inc
- Insiders 1.81%
- Institutions 98.19%
- Public & others 0.00%
- Shares outstanding 131M
- Free float 58.7M
Top funds holding SGRY.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Janus Henderson Contrarian D | 13.3M | 10.29% | +22.57% | Sep 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.48M | 1.93% | 0.00% | Sep 2026 |
| DFA U.S. Small Cap Value I | 2.37M | 1.84% | +52.55% | Sep 2026 |
| iShares Russell 2000 ETF | 2.04M | 1.58% | 0.00% | Oct 2026 |
| Vanguard Small Cap Index | 1.77M | 1.37% | -1.86% | Sep 2026 |
| ClearBridge Small Cap Growth A | 1.24M | 0.96% | 0.00% | Sep 2026 |
| Vanguard MStar Small Cap Value Index | 1.15M | 0.89% | +0.37% | Sep 2026 |
| ClearBridge Select I | 882K | 0.68% | -14.14% | Sep 2026 |
| Fidelity Small Cap Index | 876K | 0.68% | +0.19% | Aug 2026 |
| iShares Russell 2000 Value ETF | 753K | 0.58% | 0.00% | Oct 2026 |
| Dimensional US Small Cap Value ETF | 727K | 0.56% | 0.00% | Sep 2026 |
| Dimensional US Targeted Value ETF | 680K | 0.53% | 0.00% | Oct 2026 |
| DFA U.S. Targeted Value I | 553K | 0.43% | +12.79% | Sep 2026 |
| DFA U.S. Small Cap I | 521K | 0.40% | 0.00% | Sep 2026 |
| Schwab Fundamental U.S. Small CompanyETF | 506K | 0.39% | 0.00% | Oct 2026 |
| Vanguard Russell 2000 ETF | 470K | 0.36% | +2.26% | Sep 2026 |
| Strategic Advisers Fidelity US TtlStk | 424K | 0.33% | 0.00% | Sep 2026 |
| Schwab US Small-Cap ETF™ | 416K | 0.32% | +0.24% | Oct 2026 |
| Victory Integrity Small-Cap Value A | 360K | 0.28% | -6.15% | Sep 2026 |
| Dimensional US Small Cap ETF | 343K | 0.27% | +0.26% | Oct 2026 |
Top institutions holding SGRY.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Bain Capital Investors LLC | 49.9M | 38.76% | 0.00% | Jun 2026 |
| Jupiter Topco LLC | 13.9M | 10.77% | 0.00% | Jun 2026 |
| Pentwater Capital Management LP | 11.6M | 9.02% | -8.10% | Jun 2026 |
| UBS Group AG | 8.57M | 6.65% | -15.88% | Jun 2026 |
| BlackRock Inc | 6.24M | 4.84% | +10.26% | Jun 2026 |
| King Street Capital Management LP | 6.06M | 4.70% | -40.78% | Jun 2026 |
| T. Rowe Price Investment Management,Inc. | 5.92M | 4.59% | +203.44% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 5.91M | 4.59% | +19.62% | Sep 2026 |
| ClearBridge Advisors, LLC | 3.82M | 2.97% | -7.16% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 3.74M | 2.90% | +3.01% | Jun 2026 |
| Vanguard Capital Management, LLC | 3.51M | 2.72% | +2.30% | Jun 2026 |
| Davidson Kempner Capital Management LP | 3.34M | 2.59% | 0.00% | Jun 2026 |
| HSBC Holdings PLC | 2.96M | 2.30% | +54.46% | Jun 2026 |
| FMR Inc | 2.15M | 1.67% | -1.94% | Jun 2026 |
| State Street Corp | 2.14M | 1.66% | +9.58% | Jun 2026 |
| Geode Capital Management, LLC | 2.12M | 1.64% | +5.70% | Jun 2026 |
| Nomura Holdings Inc | 1.53M | 1.18% | +110.87% | Jun 2026 |
| UBS Asset Mgmt Americas Inc | 1.47M | 1.14% | -7.42% | Jun 2026 |
| LMR Partners LLP | 1.36M | 1.06% | +23.69% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 1.23M | 0.96% | +21.79% | Jun 2026 |
Surgery Partners Inc company profile
- Company name
- Surgery Partners Inc
- Ticker
- SGRY.US
- Exchange
- USA Stocks
- Listed since
- Oct 1, 2015
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 16,000
- Fiscal year end
- December
- Address
- 340 Seven Springs Way, Brentwood, TN, United States, 37027
- Phone
- 615 234 5900
- Website
- surgerypartners.com
About Surgery Partners Inc
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Surgery Partners Inc management
10- Mr. J. Eric EvansCEO & Director · born 1977
- Mr. David T. Doherty CPAExecutive VP & CFO · born 1972
- Ms. Jennifer B. Baldock J.D.Executive VP and Chief Administrative & Development Officer · born 1971
- Ms. Marissa A. BrittenhamExecutive VP & Chief Strategy Officer · born 1985
- Mr. W. Trent WebbSouth Division President · born 1980
- Mr. Justin R. OppenheimerExecutive VP & COO · born 1985
- Mr. Jon FredricksonSenior VP & Chief Information Officer
- Ms. Roxanne WomackSenior VP & Chief Compliance Officer
- Mr. Spencer ClarkGeneral Counsel & Senior VP
- Ms. Danielle BurkhalterEVP and Chief People & Transformation Officer · born 1985